Preventing infectious diseases for healthy ageing: The VITAL public-private partnership project
- PMID: 32713682
- PMCID: PMC7378501
- DOI: 10.1016/j.vaccine.2020.07.005
Preventing infectious diseases for healthy ageing: The VITAL public-private partnership project
Abstract
Prevention of infectious diseases through immunisation of the growing ageing adult population is essential to improve healthy ageing. However, many licenced and recommended vaccines for this age group show signs of waning of the protective effect due to declining immune responses (immuno-senescence) and decreasing vaccine uptake. Today's major challenge is to improve vaccine effectiveness and uptake and to deploy efficient vaccination strategies for this age group. The Vaccines and InfecTious diseases in the Ageing popuLation (VITAL) project, with partners from 17 academic & research groups and public institutes as well as seven industry collaborators, aims to address this challenge. The ambition is to provide evidence-based knowledge to local decision makers. Using a holistic and multidisciplinary approach and novel analytical methods, VITAL will provide tools that allow the development of targeted immunisation programs for ageing adults in European countries. The project is based on four pillars focussing on the assessment of the burden of vaccine-preventable diseases in ageing adults, the dissection of the mechanisms underlying immuno-senescence, the analysis of the clinical and economic public health impact of vaccination strategies and the development of educational resources for healthcare professionals. By the end of the project, a clear, detailed, and integrated program should be available for implementing a consistent, affordable, and sustainable vaccination strategy for ageing adults with regular evaluations of its impact over time.
Keywords: Elderly; Immuno-senescence; Infectious diseases; Public health; Public-private partnership; Vaccine.
Copyright © 2020. Published by Elsevier Ltd.
Conflict of interest statement
Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Giuseppe Del Giudice and Baudouin Standaert are employees and shareholders of the GSK group of companies, Stephen Lockhart is an employee and shareholder of Pfizer, and Christine Luxemburger is an employee and shareholder of Sanofi.
Figures
References
-
- Eurostat. People in the EU: who are we and how do we live; 2015. https://ec.europa.eu/eurostat/statistics-explained/index.php?title=Peopl... [accessed 06/03/2020].
-
- Eurostat. Ageing Europe, looking at the lives of older people in the EU; 2019. https://ec.europa.eu/eurostat/statistics-explained/index.php?title=Agein... [accessed 06/03/2020].
-
- Arking R. Oxford University Press; New York: 2019. Biology of longevity and aging, pathways and prospects.
-
- Eurostat. Causes of death statistics -people over 65; 2019. https://ec.europa.eu/eurostat/statistics-explained/index.php?title=Cause... [accessed].
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
